• Psychedelics in Medicine the History and Science and the Risks

  • Jan 6 2025
  • Length: 1 hr and 12 mins
  • Podcast

Psychedelics in Medicine the History and Science and the Risks

  • Summary

  • Send us a text

    Mel interviews Karina Sergi, MS, MFT Director, Psychedelic Therapy Training; Director, Diversity, Equity & Inclusion and Keith Heinzerling, MD Director, Treatment & Research In Psychedelics (TRIP) Center; Addiction Medicine.

    We discuss psychedelic associated therapy, ketamine, DMT, Psilocybin, Hallucinogen persisting perception disorder (HPPD, Ontological shock, Psychnaughts and so much more as we continue our series on mental health treatment options

    The Treatment and Research in Psychedelics clinic (TRIP) located at Pacific Neuroscience Institute. Their website:
    https://www.pacificneuroscienceinstitute.org/treatment-research-in-psychedelics/


    Support the show

    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Psychedelics in Medicine the History and Science and the Risks

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.